Shuttle Pharmaceuticals Holdings, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Shareholders held by Shuttle Pharmaceuticals Holdings, Inc. on December 16, 2022. The company is a Delaware corporation listed on The Nasdaq Stock Market LLC under the symbol SHPH and is classified as an emerging growth company.
Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting results. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the company's most recent 10-K or 10-Q filings for financial performance details.
Material Changes and Voting Results
The filing details the outcomes of four shareholder proposals:
- Election of Directors: All six nominees were elected to the Board of Directors for a one-year term. Voting results were as follows:
- Anatoly Dritschilo, MD: 9,156,733 For; 222,386 Withheld
- Milton Brown, MD, PhD: 9,042,137 For; 336,982 Withheld
- Chris Senanayake, PhD: 9,228,767 For; 150,352 Withheld
- Steven Richards: 9,228,271 For; 150,848 Withheld
- Joshua Schafer: 9,227,021 For; 152,098 Withheld
- Bette Jacobs, PhD: 9,040,276 For; 338,843 Withheld
- Ratification of Independent Auditors: Shareholders ratified the appointment of BF Borgers CPA, PC as the independent auditor for the fiscal year ending December 31, 2022.
- For: 9,236,163
- Against: 133,785
- Abstain: 9,171
- Executive Compensation (Say-on-Pay): Shareholders approved the executive compensation proposal on an advisory basis.
- For: 9,009,757
- Against: 360,900
- Abstain: 8,462
- Frequency of Say-on-Pay Votes: Shareholders voted to hold advisory votes on executive compensation annually.
- 1 Year: 9,129,620
- 2 Year: 22,973
- 3 Year: 215,950
- Abstain: 10,576
Guidance, Outlook, and Risks
This filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a report of the voting outcomes from the Annual Meeting.
Key Facts for Investor Verification
- Verify the composition of the Board of Directors following the election of the six nominees.
- Confirm the engagement of BF Borgers CPA, PC as the independent auditor for the 2022 fiscal year.
- Note that shareholders have mandated annual advisory votes on executive compensation.
- Review the company's separate financial filings (10-K/10-Q) for operational and financial performance data, as this 8-K does not contain such metrics.